164 related articles for article (PubMed ID: 38644859)
1. Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.
Zha F; Li X; Yin H; Huang D; Du Y; Zhou C
Heliyon; 2024 Apr; 10(8):e29300. PubMed ID: 38644859
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.
Kitaura A; Nakao S; Yuasa H; Tsukimoto S; Nakajima Y
Am J Case Rep; 2022 Dec; 23():e938609. PubMed ID: 36523136
[TBL] [Abstract][Full Text] [Related]
3. The Ominous Triad of Severe Takotsubo Cardiomyopathy.
Awadelkarim A; Yassin AS; Ali M; Dayco J; Saad E; Idris I; Alhusain R; Sebastian J; Afonso L
J Med Cases; 2022 Jul; 13(7):341-348. PubMed ID: 35949947
[TBL] [Abstract][Full Text] [Related]
4. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
Wei A; Peng J; Gu Z; Li J
Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
[TBL] [Abstract][Full Text] [Related]
5. Resuscitated Sudden Cardiac Arrest of a Neonate with Congenital LQT Syndrome-Associated Torsades de Pointes: A Case Report and Literature Review.
Hsu YT; Lee PC; Chen YH; Yeh SJ; Chen MR; Hsu KH; Chang CI; Lai WT; Hung WL
J Cardiovasc Dev Dis; 2022 Jun; 9(6):. PubMed ID: 35735813
[TBL] [Abstract][Full Text] [Related]
6. Application of Electromechanical Window Negativity as an Arrhythmia Risk Correlate in Acquired Long QT Syndrome.
Munshi F; Fontaine JM
JACC Case Rep; 2021 Sep; 3(12):1427-1433. PubMed ID: 34557686
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
Thomas SH; Behr ER
Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
[TBL] [Abstract][Full Text] [Related]
8. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
9. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review.
Kahlon SS; Sikandar R; Tejovath S; Nair S; Hassan D; K Patel K; Peddemul A; Mostafa JA
Cureus; 2022 Aug; 14(8):e27833. PubMed ID: 36110477
[TBL] [Abstract][Full Text] [Related]
11. Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
Takahashi K; Yamashita M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S; Takemoto M; Utsunomiya Y; Hyodo T; Ochi M; Higuchi S
Medicine (Baltimore); 2021 Sep; 100(37):e27286. PubMed ID: 34664888
[TBL] [Abstract][Full Text] [Related]
12. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
Brady WJ; DeBehnke DJ; Laundrie D
Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678
[TBL] [Abstract][Full Text] [Related]
14. Long QT Syndrome Unveiled by a Fatal Combination of Medications and Electrolyte Abnormalities.
Sethi P; Treece J; Pai V; Onweni C
Cureus; 2017 Aug; 9(8):e1581. PubMed ID: 29057193
[TBL] [Abstract][Full Text] [Related]
15. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
[TBL] [Abstract][Full Text] [Related]
16. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
17. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
Sommargren CE; Drew BJ
AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
[TBL] [Abstract][Full Text] [Related]
18. Ten-year experience in atenolol use and exercise evaluation in children with genetically proven long QT syndrome.
Kwok SY; Pflaumer A; Pantaleo SJ; Date E; Jadhav M; Davis AM
J Arrhythm; 2017 Dec; 33(6):624-629. PubMed ID: 29255512
[TBL] [Abstract][Full Text] [Related]
19. A Rare Presentation of Levetiracetam-Induced Torsades De Pointes.
Mann H; Kusayev J; Pandey S; Aryal B; Solaimanzadeh I
Cureus; 2023 Jun; 15(6):e40866. PubMed ID: 37492848
[TBL] [Abstract][Full Text] [Related]
20. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
